MiMedx Group (MDXG) Guides FY16 Above Consensus
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/14/2026
- Wall Street ends lower as Iran tensions dampen risk appetite; chipmakers drop
- SK Hynix’s record plunge drags down global chip stocks
- Oil up 9% to one-month high as US says it will blockade entire Iranian coastline, all vessels
- Ditching streaming could boost Disney stock by 40%, Wells Fargo says
- AstraZeneca stock dips as HSBC downgrades stock on 'tough path ahead'
Canaccord Genuity Raises Price target on MiMedx Group (MDXG) Following 2016 Guidance Release
December 18, 2015 8:48 AM ESTCanaccord Genuity reiterated a Buy rating on MiMedx Group (NASDAQ: MDXG), and raised the price target to $12.00 (from $10.00), following the company's release of 2016 guidance. Revenue guidance of $245M-255M equates to 30-38% growth. MiMedx noted that growth in wound care would continue... More
